Inspire Medical Systems has reported a significant 84% rise in Q1 2023 revenue, reaching $127.9 million, driven by its innovative treatments for Obstructive Sleep Apnea. The company has received FDA ...

Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...

Medicare may cover Inspire, a device to treat sleep apnea, if it is medically necessary. A doctor needs to demonstrate that people meet certain criteria and CPAP therapy has been ineffective. Inspire ...

Southern California Pulmonary and Sleep Disorders Medical Center (805-557-9930) announces the expansion of its treatment ...

Inspire Medical Systems, Inc. (NYSE:INSP), a medical technology company focused on treating obstructive sleep apnea (OSA), presented its latest corporate overview on May 5, 2025, highlighting strong ...

Inspire Medical (TASE:BLWV) Systems, Inc. (NYSE:INSP), a medical technology company focused on treating obstructive sleep apnea (OSA), presented its latest corporate overview on May 5, 2025, ...